Page results
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.
-
UCLH is considered a centre of excellence in the management of patients with Hodgkin’s and non-Hodgkin’s lymphoma.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
Dr Tyagi is a consultant neuropsychiatrist with a special interest in Tourette's syndrome and obesessive compulsive disorders (OCD)
-
The UK Chagas Hub brings together healthcare professionals, researchers, advocates and members of the Latin American community to tackle Chagas disease in the UK and contribute to global efforts to eliminate the disease.
File results
-
FOI/2021/0643 - Bank and agency staffing vacancy rates and spending
-
FOI/2021/0644 - Clinical guidelines on identification and management of maternity issues
-
FOI/2021/0645 - Software suppliers for various applications
-
FOI/2021/0649 - Physiotherapists/ occupational therapists staffing levels
-
FOI/2021/0650 - Cyber Essentials Accreditation/ Certification
-
FOI/2021/0657 - Patient list for Neuropsychiatry
-
FOI/2021/0653 - Patient Quality Safety Committee in July 2021
-
FOI/2021/0672 - Long Covid statistics
-
FOI/2021/0691 - MHPS investigations
-
FOI/2021/0700 - Treatment of rare diseases